Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
7.75
-0.09 (-1.15%)
Aug 7, 2025, 3:18 PM - Market open

Avangrid Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2016 - 2020
Debt / Equity Ratio
0.010.010.020.010.020.97
Upgrade
Debt / EBITDA Ratio
1.63-----
Upgrade
Debt / FCF Ratio
0.27-----
Upgrade
Asset Turnover
---0.100.020.07
Upgrade
Quick Ratio
11.003.334.5812.0212.550.91
Upgrade
Current Ratio
11.013.454.8712.4613.101.01
Upgrade
Return on Equity (ROE)
25.45%-78.44%-71.40%-41.64%-28.86%-39.88%
Upgrade
Return on Assets (ROA)
--39.58%-37.41%-18.40%-14.48%-10.62%
Upgrade
Return on Capital (ROIC)
-1.25%-55.48%-44.40%-20.74%-17.50%-15.67%
Upgrade
Buyback Yield / Dilution
-352.55%-22.39%-8.53%-73.52%-43.14%-4.52%
Upgrade
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q